Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Oxycodone hydrochloride
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Abtard 80mg modified-release tablets
0407020ADBMAHAI
|
Abtard | Oxycodone hydrochloride | Central Nervous System | 31 |
|
OxyNorm 20mg/2ml solution for injection ampoules
0407020ADBBAGAM
|
OxyNorm | Oxycodone hydrochloride | Central Nervous System | 30 |
|
Oxylan 60mg prolonged-release tablets (G.L. Pharma UK Ltd)
0407020ADBFAMAQ
|
Oxylan | Oxycodone hydrochloride | Central Nervous System | 27 |
|
Abtard 15mg modified-release tablets
0407020ADBMACAS
|
Abtard | Oxycodone hydrochloride | Central Nervous System | 23 |
|
Shortec 50mg/1ml solution for injection ampoules
0407020ADBJAFAN
|
Shortec | Oxycodone hydrochloride | Central Nervous System | 14 |
|
Ixyldone 20mg modified-release tablets
0407020ADBTADAG
|
Ixyldone | Oxycodone hydrochloride | Central Nervous System | 13 |
|
Ixyldone 30mg modified-release tablets
0407020ADBTAEAR
|
Ixyldone | Oxycodone hydrochloride | Central Nervous System | 13 |
|
Ixyldone 5mg modified-release tablets
0407020ADBTAAAK
|
Ixyldone | Oxycodone hydrochloride | Central Nervous System | 12 |
|
OxyNorm 50mg/1ml solution for injection ampoules
0407020ADBBAHAN
|
OxyNorm | Oxycodone hydrochloride | Central Nervous System | 12 |
|
Shortec 20mg/2ml solution for injection ampoules
0407020ADBJAEAM
|
Shortec | Oxycodone hydrochloride | Central Nervous System | 11 |
|
Ixyldone 15mg modified-release tablets
0407020ADBTACAS
|
Ixyldone | Oxycodone hydrochloride | Central Nervous System | 8 |
|
Abtard 5mg modified-release tablets
0407020ADBMAAAK
|
Abtard | Oxycodone hydrochloride | Central Nervous System | 7 |
|
Onexila XL 20mg tablets
0407020ADBQABAG
|
Onexila XL | Oxycodone hydrochloride | Central Nervous System | 7 |
|
Onexila XL 40mg tablets
0407020ADBQACAH
|
Onexila XL | Oxycodone hydrochloride | Central Nervous System | 5 |
|
Ixyldone 60mg modified-release tablets
0407020ADBTAGAQ
|
Ixyldone | Oxycodone hydrochloride | Central Nervous System | 4 |
|
Abtard 20mg modified-release tablets
0407020ADBMADAG
|
Abtard | Oxycodone hydrochloride | Central Nervous System | 3 |
|
Ixyldone 40mg modified-release tablets
0407020ADBTAFAH
|
Ixyldone | Oxycodone hydrochloride | Central Nervous System | 3 |
|
Ixyldone 80mg modified-release tablets
0407020ADBTAHAI
|
Ixyldone | Oxycodone hydrochloride | Central Nervous System | 2 |
|
Carexil 10mg modified-release tablets
0407020ADBDABAF
|
Carexil | Oxycodone hydrochloride | Central Nervous System | 1 |
|
Onexila XL 10mg tablets
0407020ADBQAAAF
|
Onexila XL | Oxycodone hydrochloride | Central Nervous System | 1 |
|
Candox 10mg modified-release tablets
0407020ADBGAAAF
|
Candox | Oxycodone hydrochloride | Central Nervous System | No data available |
|
Candox 20mg modified-release tablets
0407020ADBGABAG
|
Candox | Oxycodone hydrochloride | Central Nervous System | No data available |
|
Candox 40mg modified-release tablets
0407020ADBGADAH
|
Candox | Oxycodone hydrochloride | Central Nervous System | No data available |
|
Candox 5mg modified-release tablets
0407020ADBGACAK
|
Candox | Oxycodone hydrochloride | Central Nervous System | No data available |
|
Candox 80mg modified-release tablets
0407020ADBGAEAI
|
Candox | Oxycodone hydrochloride | Central Nervous System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.